A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis
Clinical trial NCT04255069 · UNKNOWN
Trial details
- NCT number
- NCT04255069
- Sponsor
- TaiwanJ Pharmaceuticals Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2023-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.